Tenders/BISPECIFIC ANTIBODY mimicking active factor VIII with successive deliveries to Hemophilia and Related Bleeding Disorders Treatment Centers and patient homes
Awarded🇵🇱PolandSupplies

BISPECIFIC ANTIBODY mimicking active factor VIII with successive deliveries to Hemophilia and Related Bleeding Disorders Treatment Centers and patient homes

Auto-translated from Polish
Original title: BISPECYFICZNE PRZECIWCIAŁO naśladujące aktywny czynnik VIII wraz z sukcesywnymi dostawami do Ośrodków Leczenia Hemofilii i Pokrewnych Skaz Krwotocznych oraz domów pacjentów
Narodowe Centrum Krwi
Published: Oct 22, 2026
Updated: Oct 26, 2026
Source: TED - Tenders Electronic Daily (EU)

This tender has been awarded

Awarded to Roche Polska Sp. z o.o. — €125,766,667

Browse open Health & Medical tenders in Poland

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from Polish
1. The subject of the order includes the delivery to Direct Recipients (Hemophilia and Related Bleeding Disorders Treatment Centers) of a bispecific antibody mimicking active factor VIII, along with administration kits - hereinafter referred to as the "medicinal product", for the purpose of ensuring the continuity of treatment for patients with hemophilia A complicated by an inhibitor, within the framework of implementing the health policy program of the minister competent for health entitled "National Program for the Treatment of Patients with Hemophilia and Related Bleeding Disorders for the years 2024-2028", hereinafter referred to as the "MZ program", as well as the delivery of administration kits, the organization of deliveries to patients' homes, which are understood as the patient's place of residence or permanent stay, for the indicated number of patients indicated by the National Blood Center (hereinafter NCK), the collection and disposal of single-use equipment and medical waste, ensuring strict records of the delivered medicinal product with control of drug consumption through the implementation of an electronic diary, the development and preparation of information materials regarding the safe use of medicinal products for all patients and training of all patients in the safe use of the medicinal product no later than the date of the first delivery and the delivery of containers for medical waste for all patients, meeting the requirements of applicable regulations, on the terms specified in the SWZ. 2. The health policy program of the minister competent for health entitled: "National Program for the Treatment of Patients with Hemophilia and Related Bleeding Disorders for the years 2024-2028" includes deliveries in the years 2026-2027 of the aforementioned medicinal product to Direct Recipients indicated by the NCK - Hemophilia and Related Bleeding Disorders Treatment Centers (hereinafter "OLH") and/or other entities indicated by the National Blood Center or another authorized entity, and to patients' homes, which are understood as the patient's place of residence or permanent stay. 3. Pursuant to art. 256 of the Pzp Act. The Contracting Authority may annul the public procurement procedure before the expiry of the deadline for submitting offers, if circumstances arise that make further proceedings unjustified. 4. In accordance with art. 257 of the Pzp Act. The Contracting Authority may annul the public procurement procedure if the public funds that the Contracting Authority intended to allocate for the financing of the whole or part of the order have not been granted to it. 5. The Contracting Authority reserves the right to annul the procedure, or to withdraw from the contract by 31 December 2027 with effect ex nunc without compensation for the Contractor from the Contracting Authority or the Minister of Health, if at least one of the following premises occurs: 5.1. The National Blood Center does not receive funding for the implementation of the health policy program of the Minister of Health entitled "National Program for the Treatment of Patients with Hemophilia and Related Bleeding Disorders for the years 2024-2028" in the expected year of contract execution in whole or in part allowing for contract execution. 5.2. The Minister of Health decides on the lack of modification of the program, modification of the program, withdrawal from implementation or suspension of the implementation of the "National Program for the Treatment of Patients with Hemophilia and Related Bleeding Disorders for the years 2024-2028" or makes a change to the program's content resulting in the deletion of the medicinal product that is the subject of the order/contract. 5.3. The purchase of medicinal products covered by this public procurement procedure, carried out within the framework of the "National Program for the Treatment of Patients with Hemophilia and Related Bleeding Disorders by the National Blood Center for the years 2024-2028" through the Public Procurement Office at the Minister of Health, is to be financed from funds for which final confirmation of their security will be possible after the adoption and approval of the financial plan of the National Health Fund. In view of the above, the National Blood Center - as the Contracting Authority/Purchaser -...

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on October 22, 2026. Last refreshed 23 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Narodowe Centrum Krwi

Narodowe Centrum Krwi has issued 154 procurement notices on BidsFactory, including 1 currently open and 58 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Education & Training. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: November 18, 2026.

Frequently asked questions about this tender

How much was the contract awarded for?

Roche Polska Sp. z o.o. was awarded the contract for €125,766,667. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to Roche Polska Sp. z o.o.. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Narodowe Centrum Krwi in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Sectors & Categories

Key Details

Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
Polish

Source

ted
TED - Tenders Electronic Daily (EU)
Public Procurement

Contracting Authority

Narodowe Centrum Krwi
🇵🇱Poland

Contact